UNSPSC 51281659: Neomycin sulfate

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 057Y626693. European Medicines Agency schedules Neomycin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03409MIG. Neomycin sulfate generally arises in the molecular formula C23H48N6O17S. The term 'neomycin sulfate' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule neomycin sulfate under HS 29419000 and SITC 54139.

Neomycin sulfate bears US NLM identifiers UMLS ID C0027607 and NCI Concept Code C66227. SMILES: As of Q4 2014, NEOMYCIN SULFATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51281659 Neomycin sulfate, a Commodity code, shows minimal relevant recent activity among state and local buyers—none of the recent opportunities posted under this code actually involve neomycin sulfate procurement. The Seminole County IFB solicits naloxone and drug deactivation systems; the Texas HHS RFI addresses direct-to-manufacturer pharmacy prescriptions broadly; the Tampa IFB covers general medical and first aid supplies for fire rescue operations; and the MMCAP RFP targets generic multi-source pharmaceuticals and OTC products through cooperative purchasing. While the Tampa and MMCAP opportunities touch on pharmaceutical and medical supply categories, neither names neomycin sulfate specifically, and the mismatch between the code's nominal scope and the actual goods being solicited suggests the code does not reflect active state and local market demand for this particular antibiotic product right now.

The recent opportunities that do appear under this code span diverse issuing bodies—a county health department, a state HHS commission, a city fire department, and a statewide cooperative purchasing alliance—and reach across Florida, Texas, Minnesota, and Oregon. However, because none of these solicitations target neomycin sulfate or narrow-spectrum aminoglycoside antibiotics as a primary procurement objective, this code offers little signal for vendors positioning around this specific pharmaceutical product line. Firms pursuing state and local pharmaceutical sales may find better traction monitoring broader pharmaceutical and medical supply codes where current solicitations more closely align with their product portfolios.